HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.

Conclusions: HL301 (600 mg/day) was effective and safe for symptomatic treatment of acute bronchitis. PMID: 30962409 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30962409?dopt=Abstract

Source: The Korean Journal of Internal Medicine - April 8, 2019 Category: Internal Medicine Authors: Yoon SW, Park MJ, Rhee CK, Park JH, Lee SY, Kim DJ, Kim DG, Kim JY Tags: Korean J Intern Med Source Type: research